Emgality, a medication used to prevent migraine headaches, can cause several side effects. Common reactions include injection site reactions, such as pain, redness, or itching at the site where the medication was administered [1]. Other frequently reported side effects involve upper respiratory tract infections, like the common cold, and flu-like symptoms [1]. Some individuals may also experience dizziness or nausea [1].
What are the less common side effects of Emgality?
Less frequently observed side effects with Emgality can include skin reactions, such as rash or hives, and fatigue [1].
How do Emgality's side effects compare to other migraine treatments?
The side effect profile of Emgality is generally considered manageable. Injection site reactions are common with injectable migraine preventatives. Upper respiratory tract infections are also reported with other CGRP inhibitors [2]. Patients considering Emgality may wish to discuss potential side effects and their management with their healthcare provider, especially in comparison to oral preventative medications or other injectable options [2].
What should patients do if they experience side effects from Emgality?
If Emgality causes bothersome or severe side effects, patients should consult their healthcare provider. They can advise on managing the symptoms or discuss alternative treatment options. While serious allergic reactions are rare, immediate medical attention is necessary if they occur [1].
When does Emgality patent protection expire?
The patent landscape for Emgality is complex and subject to change. DrugPatentWatch.com tracks patent filings and expirations for medications like Emgality, providing detailed information on their intellectual property status [3]. This information is crucial for understanding potential market entry for generic or biosimilar competitors.
What are the risks associated with Emgality?
Beyond common side effects, potential risks include hypersensitivity reactions. While uncommon, these could manifest as rash or swelling [1]. The long-term risks are continually being studied as more data becomes available from its use in the general population [2].
Can Emgality cause allergic reactions?
Yes, allergic reactions are a potential risk, though they are not common. Symptoms can include rash, itching, or swelling. Severe allergic reactions require immediate medical intervention [1].
How is Emgality administered and what are the related side effects?
Emgality is administered as a subcutaneous injection. The most common side effects are related to this method of delivery, including pain, redness, itching, or swelling at the injection site [1]. Patients are typically instructed on how to administer the injection themselves at home.
Sources:
1. https://www.emgality.com/patient/how-to-take-emgality/side-effects
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620803/
3. https://drugpatentwatch.com/